- Mosaic emerges from stealth with $47M Seed for robotic endovascular navigation
Mosaic emerges from stealth with $47M Seed for robotic endovascular navigation

- Francis Medical gets J&J backing as it seeks a prostate cancer indication
Francis Medical gets J&J backing as it seeks a prostate cancer indication

- Luminoah raises $25M Series B for its FDA-cleared enteral feeding system
Luminoah raises $25M Series B for its FDA-cleared enteral feeding system

- Medicaroid receives CE mark for Hinotori surgical robot
Medicaroid has received CE-MDR approval for its Hinotori surgical robot system, enabling the company to expand its robotic-assisted surgery platform into the European market. Hinotori is designed to support minimally invasive surgery with eight-axis robotic arms that replicate surgeons' hand movemen

- xDot Medical can begin FDA IDE study of vascular closure device
xDot Medical has received FDA investigational device exemption (IDE) approval to begin a pivotal clinical trial of its Access Management System (AMS) for closing large-bore femoral arterial and venous access sites following catheter-based procedures. The study will enroll 266 patients, including rol

- Movmedix gets FDA nod for third-gen synthetic shoulder implant
Movmedix has received FDA 510(k) clearance for its third-generation LARS ACJ synthetic ligament implant, marking the company's first U.S. regulatory approval and enabling the launch of the shoulder repair system in the United States. The implant is designed to treat acromioclavicular (ACJ) joint inj

- Neo Medical launches access platform for minimally invasive spine surgery
Neo Medical has launched its Neo Instant MIS Access platform in the United States, expanding its minimally invasive spine surgery offering for thoracic, lumbar, and sacral procedures. The system is designed to simplify posterior MIS workflows by removing reliance on capital equipment, reusable instr

- First patient enrolled in study of Reflow Medical’s Spur system
Reflow Medical has enrolled the first patient in the DEEPER CHALLENGE study evaluating its Spur Peripheral Retrievable Scaffold System for below-the-knee treatment in patients with chronic limb-threatening ischemia (CLTI). The single-center study at the Medical University of Graz will enroll up to 4

- Boustead acquires majority stake in urology robotics company UroMedTech
Boustead Singapore Limited has acquired a 60% stake in UroMedTech Pte Ltd through a S$6 million equity investment, expanding its healthcare technology portfolio. UroMedTech develops the UroMaster robotic platform for prostate cancer diagnosis, which is approved in Singapore, Malaysia, Australia, and

- Median Technologies’ eyonis LCS obtains CE marking
Median Technologies has announced that its AI-powered software, eyonis® LCS, has obtained CE marking as a Class IIb medical device. Granted by the French notified body GMED, this certification confirms compliance with European standards for patient safety and clinical efficacy, allowing the company

- Materna Medical closes $5 Million B3 financing to fuel growth
Materna Medical, a Mountain View, California-based OBGYN platform company, has successfully closed a $5 million B3 financing round. The investment was led by InnovaHealth Partners, Wavemaker360 Health, and Band of Angels, with participation from existing investors. This new capital positions the com

- Francis Medical announces publication of VAPOR 2 pivotal trial results
Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology , showcasing highly positive results for its Vanquish Water Vapor Ablation System. The trial evaluated the first 110 patients diagnosed with localized, intermediate-risk prostate cancer a












